Surface expression method of peptides P5 and Anal3 using the...

Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C435S252330, C424S093200

Reexamination Certificate

active

08080402

ABSTRACT:
The present invention relates to a method for expressing each of peptide antibiotics P5 3 and Anal3 35 having amphiphilicity and showing antibacterial, antifungal and anticancer activities 61, 63, 65, 67, 69, 71, on the microbial surface, using a vector containing outer membrane protein genes (pgsBCA) that are derived fromBacillussp. strains and involved in the synthesis of poly-gamma-glutamate. Moreover, the present invention relates to lactic acid-forming bacteria having each of the peptide antibiotics P5 15 and Anal3 43 expressed on their surface, and the use thereof. According to the present invention, the peptide antibiotics can be expressed on the surface of various microorganisms transformed with the surface expression vectors. The inventive method for the surface expression of the peptide antibiotics allows the peptide antibiotics to be mass-produced without a purification process. Thus, the inventive method has very high industrial applicability. Further, the present invention can be applied to other peptide antibiotics besides P5 3 and Anal 3 35.

REFERENCES:
patent: 7255855 (2007-08-01), Sung et al.
patent: 7553636 (2009-06-01), Sung et al.
patent: 03014360 (2003-02-01), None
Luis M. Cintas et al.; Enterocins L50A and L50B, Two Novel Bacteriocins fromEnterococcus faeciumL50, Are Related to Staphylococcal Hemolysins; Journal of Bacteriology; Apr. 1998; pp. 1988-1994; vol. 180, No. 8; American Society for Microbiology.
Charles L. Bevins et al.; Peptides from Frog Skin; Annu. Rev. Biochem; 1990; pp. 395-414; No. 59; Annual Reviews, Inc.
Kenneth T. Miyasaki et al.; β-sheet antibiotic peptides as potential dental therapeutics; International Journal of Antimicrobial Agents 9; 1998; pp. 269-280; Elsevier Science B.V.
Hans G. Boman; Anitbacterial Peptides: Key Components Needed in Immunity; Cell; Apr. 1991; pp. 205-207; vol. 65; Cell Press.
Hans G. Boman; Peptide Antibiotics and Their Role in Innate Immunity; Annu. Rev. Immunol.; 1995; pp. 61-92; No. 13; Annual Reviews.
H.G. Boman et al.; Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids; Febs Letters; Dec. 1989; pp. 103-106; vol. 259, No. 1; Elsevier Science Publishers B.V. (Biomedical Division).
D. Wade et al.; Antibacterial peptides designed as analogs or hybrids of cecropins and melittin; Int. J. Peptide Protein Res.; 1992; pp. 429-436; No. 40.
Author Unknown; Antibacterial peptide from H. pylori; Nature; Apr. 1999; pp. 671-672; vol. 398; Macmillan Magazines Ltd.
Alain Charbit et al.; Presentation of Two Epitopes of the preS2 Region of Hepatitis B Virus on Live Recominant Bacteria; The Journal of Immunology; Sep. 1987; pp. 1658-1664; vol. 139, No. 5; The American Association of Immunologists.
Marja Agterberg et al.; Outer membrane PhoE protein ofEscherichia colias a carrier for foreign antigenic determinants: immunogenicity of epitopes of foot-and-mouth disease virus; Vaccine; Feb. 1990; vol. 8; Butterworth & Co. (Publishers) Ltd.
Franco Felici et al.; Selection of Antibody Ligands from a Large Library of Oligopeptides Expressed on a Multivalent Exposition Vector; Journal of Molecular Biology; 1991; pp. 301-310, vol. 222; Academic Press Limited.
Patrick Fuchs et al.; Targeting Recombinant Antibodies to the Surface ofEscherichia Coli: Fusion to a Peptidoglycan Associated Lipoprotein; Bio/Technology; Dec. 1991; pp. 1369-1372; vol. 9.
J.A. Francisco et al.; Transport and Anchoring of β-Lactamase to the External Surface ofEscherichia coli; Proc. Natl. Acad. Sci.; Apr. 1992; pp. 2713-2717; vol. 89; USA.
Lisbeth Hedegaard et al.; Type 1 fimbriae ofEscherichia colias carriers of heterologous antigenic sequences; Gene; 1989; pp. 115-124; vol. 85; Elsevier Science Publishers B.V. (Biomedical Division).
Heung-Chae Jung et al.; Surface display ofZymomonas mobilislevensucrase by using the ice-nucleation protein ofPseudomonas syringae; Nature Biotechnology; Jun. 1998; pp. 576-580; vol. 16; Nature Publishing Group.A.
Heung-Chae Jung et al.; Expression of Carboxymethylcellulase on the Surface ofEscherichia ColiUsingPseudomonas syringaeIce Nucleation Protein; ScienceDirect—Enzyme and Microbial Technology; 1998; Elsevier Science, Inc.
Jong-Soo Lee et al.; Surface-displayed viral antigens onSalmonellacarrier vaccine; Nature Biotechnology; Jun. 2000; pp. 645-648; vol. 18; North America Inc.
M.G. Komacker et al.; The normally periplasmic enzyme β-lactamase is specifically and efficiently translocated through theEscherichia coliouter membrane when it is fused to the cell-surface enzyme pullulanase; Molecular Microbiology; 1990; pp. 1101-1109; vol. 4, No. 7.
Thomas Klauser et al.; Extracellular transport of cholera toxin B subunit usingNeisseriaIgA protease β-domain: conformation-dependent outer membrane translocation; The EMBO Journal; 1990; pp. 1991-1999; vol. 9, No. 6; Oxford University Press.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Surface expression method of peptides P5 and Anal3 using the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Surface expression method of peptides P5 and Anal3 using the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Surface expression method of peptides P5 and Anal3 using the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4260441

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.